Literature DB >> 1514505

Efficacy of lipid profiles in prediction of coronary disease.

W B Kannel1, P W Wilson.   

Abstract

National guidelines in the United States and Europe have stimulated interest in controlling blood lipid levels to prevent CHD. In this review, the efficiency of lipid profiles in predicting CHD has been examined, and total cholesterol, HDL and LDL cholesterol, and triglyceride values have been compared on the basis of 12 to 14 years of surveillance in the Framingham Study. The average value of total cholesterol and LDL cholesterol in patients who had coronary disease was at or below values that are considered dangerous, which indicates the need for more specific and sensitive lipid profiles. Measurement of LDL cholesterol levels predicted CHD only marginally better than measurement of serum total cholesterol. Measurement of triglyceride levels was the weakest predictor. The total cholesterol to HDL cholesterol ratio was the most efficient predictor both in those with apparently safe and those with abnormal cholesterol values. Measurement of HDL cholesterol was the best single lipid predictor and use of this measurement avoids needlessly alarming or falsely reassuring persons at risk for CHD who have high total cholesterol values. Since the risk associated with any serum cholesterol value varies over a 10-fold range depending on coexistent cardiovascular risk factors, these lipid factors must be taken into account in judging the hazards and efficacy of treatment needed. Evidence is available that controlling elevated cholesterol by diet and administration of pharmaceutical agents can reduce the rate of coronary events, slow progression of angiographically visualized lesions, and regress xanthomata.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514505     DOI: 10.1016/0002-8703(92)90288-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

Review 1.  Biomarkers and HIV-associated cardiovascular disease.

Authors:  Jason V Baker; Daniel Duprez
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  Circulating lipid levels and risk of coronary artery disease in a large group of patients undergoing coronary angiography.

Authors:  Daniel E Platt; Michella Ghassibe-Sabbagh; Sonia Youhanna; Jörg Hager; Jean-Baptiste Cazier; Yoichiro Kamatani; Angelique K Salloum; Marc Haber; Jihane Romanos; Bouchra Doueihy; Francis Mouzaya; Samer Kibbani; Hana Sbeite; Mary E Deeb; Elie Chammas; Hamid El Bayeh; Georges Khazen; Dominique Gauguier; Pierre A Zalloua; Antoine B Abchee
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

3.  Lipid disorders in hospital attendants in Kumasi, Ghana.

Authors:  F B Micah; B C Nkum
Journal:  Ghana Med J       Date:  2012-03

Review 4.  Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.

Authors:  Jose Manuel Izquierdo-Palomares; Jesus Maria Fernandez-Tabera; Maria N Plana; Almudena Añino Alba; Pablo Gómez Álvarez; Inmaculada Fernandez-Esteban; Luis Carlos Saiz; Pilar Martin-Carrillo; Óscar Pinar López
Journal:  Cochrane Database Syst Rev       Date:  2016-11-26

5.  PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY.

Authors:  Wm James Howard; Marie Russell; Jerome L Fleg; Mihriye Mete; Tauqeer Ali; Richard B Devereux; James M Galloway; James D Otvos; Robert E Ratner; Mary J Roman; Angela Silverman; Jason G Umans; Neil J Weissman; Charlton Wilson; Barbara V Howard
Journal:  J Clin Lipidol       Date:  2009-10-01       Impact factor: 4.766

6.  VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Ronald A Thisted; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

7.  Clinical significance of abnormal electrocardiographic findings in individuals aging with spinal injury and abnormal lipid profiles.

Authors:  Yaga Szlachcic; LeeAnne Carrothers; Rodney Adkins; Robert Waters
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

8.  Plasma cholesterol and other cardiac risk factors in adolescent girls.

Authors:  M A Bermingham; E Jones; K Steinbeck; K Brock
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

9.  Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

Authors:  Iris Navarro-Millán; Christina Charles-Schoeman; Shuo Yang; Joan M Bathon; S Louis Bridges; Lang Chen; Stacey S Cofield; Louis J Dell'Italia; Larry W Moreland; James R O'Dell; Harold E Paulus; Jeffrey R Curtis
Journal:  Arthritis Rheum       Date:  2013-06

10.  Resistance training with soy vs whey protein supplements in hyperlipidemic males.

Authors:  Carol A Denysschen; Harold W Burton; Peter J Horvath; John J Leddy; Richard W Browne
Journal:  J Int Soc Sports Nutr       Date:  2009-03-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.